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JPET 239806 4 ABSTRACT: Dieldrin is a legacy organochlorine pesticide that is persistent in the environment, despite being discontinued from use in North America since the 1970s. Some epidemiological studies suggest that exposure to dieldrin is associated with increased risks of neurodegenerative disease and breast cancer by inducing inflammatory responses in tissues as well as oxidative stress. However, the direct effects of organochlorine pesticides on the heart have not been adequately addressed to date given that these chemicals are detectable in human serum and are environmentally persistent, thus individuals may show latent adverse effects in the cardiovasculature system due to chronic, low dose exposure over time. Our objective was to determine whether low level exposure to dieldrin at an environmentally relevant dose results in aberrant molecular signaling in the vertebrate heart. Using transcriptomic profiling and immunoblotting, we determined the global gene and targeted protein expression response to dieldrin treatment, and show that dieldrin effects gene networks in the heart that are associated to the development of cardiovascular disease, specifically cardiac arrest and ventricular fibrillation. We report that genes regulating inflammatory responses, a significant risk factor for cardiovascular disease, are upregulated by dieldrin while transcripts related to lysosomal function are significantly downregulated.
To verify these findings, proteins in these pathways were examined with immunoblotting, and our results suggest that dieldrin constitutively activates Akt/mTOR signalling and downregulates lysosomal genes, participating in autophagy. Our data demonstrate that dieldrin induces genes associated with cardiovascular dysfunction and compromised lysosomal physiology, thereby identifying a novel mechanism for pesticide-induced diseases.
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Introduction
The widespread use of pesticides negatively impacts our environment, thereby rendering human health susceptible to chronic diseases, such as obesity, cancer, and neurodegeneration (Alavanja et al., 2004; Lee et al., 2014) . Dieldrin, an organochlorine pesticide, is a persistent chemical that was banned from agricultural use in the 1970s and was withdrawn from residential use by the 1990s. However, due to a long half-life, dieldrin persists in the environment (Jorgenson, 2001) and has been associated to human diseases such as Alzheimer's disease, (Singh et al., 2012; Singh et al., 2013) Parkinson's disease, (Fleming et al., 1994; Weisskopf et al., 2010; Baltazar et al., 2014) and obesity (Cupul-Uicab et al., 2013) . Acute (Hung et al., 2015) and chronic pesticide exposure (Sergeev and Carpenter, 2005; Kim et al., 2015) are also associated with cardiovascular disease outcomes. Notably pre-natal exposure to pesticides disrupts cardiovascular development with significant relation to congenital heart disease (Gorini et al., 2014) . Thus, studies are warranted to determine the mechanisms related to pesticide-induced cardiotoxicity in both the juvenile and adult heart.
Exposure to dieldrin and several other organochlorine pesticides (OCP) have been associated to cardiovascular disease. For instance, elevated circulating levels of OCPs are associated with peripheral artery disease (Min et al., 2011) , insulin resistance (Lee et al., 2011) and cardiovascular disease development (Ljunggren et al., 2014) .
Additionally, sub-lethal endosulfan exposure in rabbits results in myocardial apoptosis (Ozmen, 2013) , while chronic lindane exposure in rats led to oxidative stress and loss of myofibril integrity (Ananya et al., 2005) . At the molecular level, dieldrin exhibits toxicity by targeting mitochondria and the endoplasmic reticulum (Kitazawa et al., 2003) . This article has not been copyedited and formatted. The final version may differ from this version. JPET Fast Forward. Published on April 6, 2017 as DOI: 10.1124 at ASPET Journals on April 12, 2017 jpet.aspetjournals.org
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JPET 239806 6 Dieldrin exposure also activates Protein Kinase B (Akt) /mTOR (mechanistic target of rapamycin) pathway, a major regulator of cell growth and proliferation (Briz et al., 2011) .
The Akt/mTOR pathway also inhibits lysosomal autophagy (Jung et al., 2010) .
Autophagy, an evolutionarily conserved cellular mechanism for the lysosomal degradation of cytosolic components including proteins and organelles, is known to respond to cell stress, including exposure to environmental pollution, and failure of this response could result in proteotoxicity . Autophagy ensures cardiomyocyte survival by clearing toxic protein aggregates that accumulate in the cell during cardiac stress (Martinet et al., 2009 ). However, whether dieldrin exposure induces cardiac stress by altering autophagy is currently unknown.
We hypothesized that activation of the Akt/mTOR pathway by dieldrin suppresses lysosomal gene expression and autophagy signaling. To examine the cardiac effects of dieldrin, we used adult zebrafish (Danio rerio), a freshwater teleost that is a popular model for studying human diseases (Lieschke and Currie, 2007) and for screening and validating drugs and chemicals inducing cardiotoxicity (Milan et al., 2006; McGrath and Li, 2008; Liu et al., 2014) . At the genetic level, approximately 70 percent of human genes have a zebrafish orthologue, and 82 percent of human genes with a known relation to morbidity have at least one zebrafish orthologue (Howe et al., 2013) , thus the zebrafish is a relevant model for human disease. Here, we show that dietary dieldrin exposure is sufficient to elevate mTOR signaling and its downstream targets, reducing transcripts related to autophagy, and inducing aberrations in transcripts governing functional outcomes in the zebrafish heart. 
Methods

Experimental design
Six month old zebrafish (AB strain) were fed feed mixed with dieldrin at different concentrations for 21 days. Water parameters (mean ± standard deviation) during the experiment were as follows; temperature = 25.5⁰C (±1.5), dissolved oxygen = 84.1% (± 8.4), and pH = 6.54 (±0.57). Fish were housed with a photoperiod of 16 hours light and 8 hours dark. All procedures involving animals conformed to Canadian Council on Animal Care (CCAC) standards for fish handling and were approved by University of New Brunswick, Saint John animal care committee. In order to ensure fish were only exposed to dieldrin in the diet, 50 percent of the water in the tanks was changed every three days, and uneaten food and fish waste product were removed. Additionally activated carbon was added to the tanks to prevent exposure to dieldrin from the water which is effective (Bandala et al., 2006) . Dieldrin was incorporated into the feed through dissolution in olive oil and then mixed with the diet, while control diet was coated with olive oil only. Analytical chemistry analysis for feed has been published elsewhere (Cowie et al., 2017) . Briefly, control feed contained no detectable dieldrin whereas mean dieldrin in feed was 0.03, 0.15, 1.8 µg/g of dry-weight feed for the low, medium and high dose, respectively. The treatments were significantly different from the control group and in this manuscript; the feed concentrations are used to describe treatments.
Dieldrin was also measured in the whole animals. Dieldrin in zebrafish fed the control diet was at the detection limit whereas concentration (µg dieldrin/g dry weight) in fish was 0.011 in low, 0.058 medium, and 0.47 and high treatments. The mean wet weight concentrations of dieldrin in whole zebrafish were 3.50, 17.6, and 148 ng/g wet weight JPET 239806 9 instructions, starting with 45 ng of RNA input. Quantification of the labelled cRNA was performed using the Nanodrop 2000 Spectrophotometer (Nanodrop; Thermo Sciencific, Buckinghamshire, UK). Cyanine 3 dye concentration (pmol/μl), and cRNA concentration were measured for each sample. The total yield of cRNA in μg, and specific activity of Cy3 (concentration of Cy3/concentration of cRNA) were calculated to determine whether labelling and amplification was successful. Microarray analysis with Agilent 4x44k microarrays proceeded if the total yield of cRNA was greater than 1.65 μg and the specific activity of Cy3 was greater than 6 pmol per μg of cRNA; criteria met by all samples.
Microarray hybridization and analysis
Microarray hybridization followed the Agilent One-Color Microarray-Based Gene Expression Analysis protocol for Agilent 4x44k zebrafish v3 microarray slides. Following hybridization, slides were scanned with the Agilent Microarray Scanner at a resolution of 5μm. Raw expression data along with tif images were extracted by Agilent Feature Extraction Software (v10.7.3.1). All microarray data reported in this study follow established guidelines "Minimum Information About a Microarray Experiment (MIAME)" (http://www.ncbi.nlm.nih.gov/geo/info/MIAME) and are located in the Gene Expression Omnibus (GEO, Gene Ontology Consortium, 2000) (GSE87294). The arrays were quality control checked using a distribution analysis that plots the intensity distributions of each microarray slide to ensure these distributions are relatively equal. One microarray in the control group show localized intensity outliers in the center of the array and these features were manually removed from the analysis. Box plots of normalized intensity also showed that the intensity distribution was not different across slides. The This article has not been copyedited and formatted. The final version may differ from this version.
JPET Fast Forward. Published on April 6, 2017 as DOI: 10.1124/jpet.116.239806 at ASPET Journals on April 12, 2017 jpet.aspetjournals.org Downloaded from microarray data were analyzed using JMP® Genomics (v6) to identify differentiallyexpressed genes (DEGs) using a one-way ANOVA followed by a FDR (5%). Data were first normalized using Quantile normalization and probes falling below the detection limit of the microarrays (2.5) were assigned an intensity value = 2.5. Bioinformatic analysis (Sub-network enrichment analysis and expression targets) was performed in Pathway Studio 9.0 (Ariadne, Rockville, MD, USA, now Elsevier) using the ResNet 9.0, a mammalian database curated by Ariadne (Nikitin et al., 2003) .
Gel electrophoresis and immunoblotting
Frozen whole zebrafish hearts (80 in total) were pooled into tubes on the basis of the tank they originated from while keeping sexes separate, i.e. two separate lysates (male or female) were generated from one tank (five fish), for a total of four female and four male biological replicates per treatment. The pooled hearts were homogenized in 60 μl of ice cold lysis buffer as previously described (Bartlett et al., 2016) . The homogenates were allowed to settle on ice before being centrifuged for 30 minutes at 1200 g. The supernatant was aspirated from the pellet and stored in 1.5 ml centrifuge tubes at -80⁰ C.
Total protein concentration in pooled heart samples was estimated using the Pierce BCA Protein Assay Kit (Thermo Fisher Scientific Inc., Waltham, MA, USA, Cat#: imaged with the Bio-Rad Chemidoc MP imaging system. Normalized signal intensity of quantified immunoblots was analysed in GraphPad Prism 6 (GraphPad, La Jolla, CA, USA). A two-way analysis of variance (ANOVA) was conducted to test effect of sex on dieldrin treatment, however the factor was not significant, nor was there an interaction.
One-way ANOVA was used to determine if the groups (comprised of two male samples and two female samples) were significantly different, and if so, Dunnett's post-hoc test or unpaired two-tailed t-tests were used to compare individual groups.
This article has not been copyedited and formatted. The final version may differ from this version.
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Results
Transcriptomics analysis of the zebrafish heart following dieldrin exposure
Analysis of gene expression in response to dieldrin treatment resulted in 627 differentially expressed transcripts by either the measured 1.8 μg/g dose or 0.15 μg/g dose of dieldrin treatment (p<0.01). Furthermore, between the 1.8 μg/g dose and the 0.15 μg/g dose of dieldrin, there were 47 transcripts differentially expressed (p<0.01).
Transcripts significantly regulated by both doses include myl9b which is involved in muscle contraction, and cdkn1b, involved in cell cycle arrest. Furthermore, two transcripts which are associated with endosome regulation, mucolipin-3 and map1lc3a
were downregulated in the heart following both treatment doses of dieldrin. All microarray gene expression data can be found in supplementary appendix 1. After applying a stringent false discovery rate of 5%, one transcript in the 1.8 µg/g dieldrin treatment group, sphingosine-1-phosphate receptor 5b, was significantly different compared to the control group. Pathway analysis however was conducted on all the transcriptomic data as per our established methods (Cowie et al., 2017) .
Subnetwork enrichment analysis (SNEA) revealed that gene networks associated with 225 diseases were altered in the heart by either the 1.8 μg/g or 0.15 μg/g dose of dieldrin, and gene networks associated with 39 diseases were altered in zebrafish heart by both doses. All SNEA for diseases can be found in supplementary appendix 2.
Several of the disease networks identified by SNEA analysis pertained to cardiovascular pathophysiology, including artery calcification, rheumatic heart disease, angina pectoris and cardiac arrest ( Figure 1C , Table 1 ). Specific genes related to cardiac arrest This article has not been copyedited and formatted. The final version may differ from this version.
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JPET 239806 13 included the fos (FBJ murine osteosarcoma viral oncogene homolog, fold change = 4.42, p = 0.001) and jun (fold change = 2.04, p = 0.005) complex, two proteins which dimerize to form a transcription factor regulating cell proliferation. Furthermore, angiotensin converting enzyme (ace) expression, a positive regulator of blood pressure, was increased > 2 fold (fold change = 2.11, p= 0.04), while oxytocin, a negative regulator of blood pressure was decreased >2 fold (fold change = -2.14, p = 0.048, Figure 1A ). Transcripts related to ventricular fibrillation were also identified as being altered by dieldrin. These genes included ace, as well as catecholamine receptor adrenoceptor β 2ab (fold change = 2.99, p = 0.021). Two potassium channels specific to myocytes, which regulate membrane potential, were also upregulated with dieldrin including potassium inwardly-rectifying channel, subfamily J, member 11, like (kcnj11l) was increased (fold change = 1.61, p = 0.03) along with potassium voltage-gated channel, subfamily H (eag-related), member 2a, kcnh2a (fold change = 1.33, p = 0.049, Figure 1B ).
Dieldrin treatment alters inflammatory and lysosomal processes
Analysis of microarray results by SNEA revealed that 196 cell processes were regulated by the 1.8 μg/g dose of dieldrin while 129 cell processes were regulated by the 0.15 μg/g dose in zebrafish hearts at p<0.05. SNEA analysis showed that 56 cell processes were regulated by both the 0.15 μg/g and 1.8 μg/g doses. All SNEA for cell processes can be found in supplementary appendix 2. Cell processes which we determined to be related to cardiovascular metabolism (Table 2) were further investigated to identify their component genes. Processes regulating inflammatory stress were significantly upregulated by dieldrin (median change = 1.0008, p = 0.041).
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Specific genes that were altered by the 1.8 μg/g dose of dieldrin treatment include the positive mediators of inflammation: interleukin 6 (fold change = 1.46, p = 0.034) and
TNFα-induced protein 2 (fold change = 1.24, p = 0.020). Negative regulators of inflammation were downregulated in the heart by the 1.8 μg/g dose of dieldrin such as Nuclear Factor-κB repressing factor (fold change = -1.15, p =0.047) and Nuclear Factor-κB inhibitor interacting RAS-like (fold change = -1.2, p=0.042, Figure 3A ). Enrichment analysis also identified several processes related to lipid metabolism that were significantly altered in the heart by 1.8 μg/g dose of dieldrin ( Figure 3 ). Other cell processes identified as being differentially upregulated in the heart by the 1.8 µg/g dose of dieldrin include heart muscle growth and muscle development, along with a down regulation of processes involved in myocyte function (Table 2) , which taken together with the diseases identified as being differential regulated, indicate that dieldrin exposure render zebrafish cardiomyocyte susceptible to injury.
SNEA analysis also identified gene networks related to protein degradation, specifically those pertaining to lysosomal lumen acidification and autophagy. Transcripts that play a role in these processes are differentially regulated by dieldrin (Table 2) .
Significantly altered transcripts related to lysosomal lumen acidification include the lysosomal H+ transport proteins: atp6v1ba, atp6v1e1, and atp6ap1, which were all significantly (p < 0.05) downregulated in the heart by the 1.8 μg/g dose of dieldrin. Furthermore, two membrane proteins required for lysosomal trafficking and acidification, mucolipin1 (mcoln1) and mucolipin3 (mcoln3), are downregulated in the heart following the 1.8 μg/g dose of dieldrin (Fold change = -1.49 and -1.50, p = 0.039 and 0.004, respectively), while MCOLN3 is also downregulated in the heart by the 0.15 μg/g This article has not been copyedited and formatted. The final version may differ from this version.
JPET Fast Forward. Published on April 6, 2017 as DOI: 10.1124/jpet.116.239806 at ASPET Journals on April 12, 2017 jpet.aspetjournals.org Downloaded from treatment (Fold change= -1.42, p= 0.005). We observed that the expression of genes involved in lysosomal autophagy were significantly downregulated in the heart in response to dieldrin and these included microtubule associated protein 1, light chain 3 A and B (LC3A/B). LC3A was decreased in the heart by both doses of dieldrin (1.8 μg/g dose: Fold change = -1.21, p = 0.009; 0.15 μg/g dose: Fold change = -1.26, p = 0.001) while LC3B was decreased in the fish fed 0.15 μg/g dieldrin in the feed (Fold change = -1.23, p = 0.047).
Dieldrin treatment increases mTOR signalling
Given that genes critical for lysosomal function was identified by microarray analysis as being suppressed at the transcript level by dieldrin, we more closely examined the pathway that regulates the lysosome (Akt/mTOR) at the protein level.
Immunoblotting for the mechanistic target of rapamycin (mTOR) and its upstream and downstream targets revealed hyper-phosphorylation and activation of the pathway in dieldrin treated zebrafish hearts (Figure 4 ). Akt/protein kinase b, an upstream activator of mTOR, shows a significant (F(3,12)=5.502, p = 0.013) increase in phosphorylation at serine 473 in fish fed both the 1.8 μg/g (p < 0.05) and 0.15 μg/g (p < 0.01) treatment groups compared to control ( Figure 4B ). Likewise, mTOR phosphorylation was significantly (F(3, 12)=3.517, p = 0.049) increased in hearts from the 1.8 μg/g group (p < 0.05) compared to control ( Figure 4C ). The downstream target of mTOR, ribosomal s6 kinase (p70s6k) is also significantly (F(3,12)= 4.709, p = 0.021) hyper-phosphorylated in zebrafish from the 1.8 μg/g treatment group (p < 0.01) compared to control ( Figure 4D ).
These results correspond to our microarray findings, which indicated that expression targets of p70S6K and p90S6K (downstream targets of mTOR), negative regulators of To test our hypothesis that dieldrin alters lysosomal function, which was suggested by the microarray analysis, we immunoblotted for autophagy related targets ( Figure 6 ). We determined that the expression of cathepsin D, a lysosomal protease has significantly reduced protein expression (F(3,12)=3.662, p=0.044) in zebrafish from both the 1.8 μg/g and 0.15 μg/g dieldrin treatment groups compared to the control (p<0.05, ttest, Figure 6B ). Immunoblotting for lysosomal associated membrane protein 2A (LAMP-2A) and heat shock cognate of 70 kDa (hsc70) showed that they were unchanged in fish from the dieldrin treated groups compared to the control ( Figure   6C /D). However, the gene expression analysis identified macroautophagy transcripts to be differentially regulated, while we were only able to examine the expression of chaperone mediated autophagy proteins.
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Discussion
The overall goal of this study was to determine if dieldrin at a low, environmentally relevant dose results in cardiac injury. To achieve this, we examined the effect of a 3 week dieldrin (model legacy OCP) exposure in hearts of zebrafish. The total body burden of dieldrin achieved by the three week feeding is comparable to what is observed in some wild fish. Dieldrin total body burden in largemouth bass after four months of exposure at a contaminated site was roughly 500 ng/g wet weight (Martyniuk et al., 2010b) compared to our study in which we saw a total body burden of ~150 ng/g wet weight after three weeks of feeding a 1.8 µg/g dose. It is more difficult to compare the concentrations achieved in our study to human health as most human data is based upon serum, breast milk, and individual tissue concentrations (Brock et al., 1998; Jorgenson, 2001; Fujii et al., 2012) , while our study measured whole body burden exclusively. Another area of caution in this study is the sex-specific effect of dieldrin.
Our gene expression analysis was performed on hearts from adult female zebrafish, while the western blot analysis included both male and female fish. Given that previous studies have identified a sexually dimorphic response to dieldrin (Martyniuk et al., 2013) , future experiments should investigate whether the same transcriptome networks are altered in male fish. This is the first study to reveal that gene networks associated with cardiovascular disease, along with several cellular processes related to the development of cardiac injury, are altered by three weeks of dieldrin treatment in adult zebrafish. Together these data suggest that dieldrin causes cardiomyocyte injury which is due to altered status of growth, metabolic dysregulation, and lysosomal stress. 
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Our first aim was to characterize the global gene expression response in female zebrafish hearts to 21 day dieldrin treatment, and use bioinformatics approaches to relate the gene expression data to cell processes and diseases. This is one of the few reports on the effect of dieldrin in the vertebrate heart. Others have reported that aldrin, dieldrin and endrin all inhibit cardiac sarcoplasmic reticulum calcium pump activity in a dose dependent manner (Mehrotra et al., 1989) . Interestingly, our data also indicate that target genes regulating ion pump function are downregulated by dieldrin treatment. In the current study, we demonstrate via functional enrichment analysis of microarray data that alterations in gene networks regulating the susceptibility to cardiac arrest, ventricular fibrillation, and arteriole stiffness are associated with dieldrin exposure. Functional enrichment analysis identified several genes which are related to ventricular fibrillation (VF) lethal form of cardiac arrhythmia. Notably kcnj11l, also known as Kir6.2, part of a family of potassium-ATP channels, was upregulated by dieldrin (Medeiros-Domingo et al., 2010) . Interestingly, dieldrin also increased the expression of the voltage-gated potassium channel kcnh2. Gain of function mutations for KCNH2 result in arrhythmias such as arterial fibrillation, and short or long QT syndromes (Hong et al., 2005) . Carriers of KCNH2 gain of function mutations have an increased chance of ventricular arrhythmias resulting in sudden cardiac death (Brugada et al., 2004) .
Furthermore, others found that downregulation of Kir6.2 resulted in protection of ischemia induced VF, (Tsuburaya et al., 2011) . We observe that the 1.8 μg/g dose of dieldrin also increases genes in networks related to cellular dedifferentiation in addition to muscle development and growth, which are processes characteristic of zebrafish heart regeneration in response to injury (Jopling et al., 2010) . This article has not been copyedited and formatted. The final version may differ from this version.
Preclinical evidence from mammalian cardiovascular research indicates that vasculo-muscular stiffness and injury in the heart is an outcome of excess inflammation.
In our study transcripts related to inflammatory response were shown to be modulated in the zebrafish heart after 21-day treatment with dieldrin. Previous reports have suggested that acute dieldrin injection or long-term exposure activates a transcriptional inflammatory response in the largemouth bass hypothalamus (Martyniuk et al., 2010a; Martyniuk et al., 2010b ). Likewise, dieldrin was able to induce pro-inflammatory cytokine production in human neutrophils, along with the activation of other neutrophil functions (Pelletier et al., 2001) . Our microarray results indicate that interleukin 6 (IL-6) is upregulated in response to dieldrin treatment. Notably our data also show that fos and jun are both significantly upregulated in response to dieldrin, which combine to form activator protein 1 (AP-1), that induces muscle differentiation and proliferation (Shaulian and Karin, 2002; Moore-Carrasco et al., 2006) . AP-1 overexpression is associated with cardiac hypertrophy (Herzig et al., 1997) and chronic heart failure (Frantz et al., 2003) .
Interestingly, ace is upregulated by dieldrin in our results, and angiotensin II both activates and induces expression of AP-1 (Herzig et al., 1997; van Wamel et al., 2001) . ACE was also identified as a gene related to the development of arterial stiffness in zebrafish treated with the high dose of dieldrin. An inflammatory response initiated by dieldrin treatment may be another mechanism of AP-1 activation, considering proinflammatory cytokines induce expression of both FOS and JUN (Karin et al., 1997) . apoptosis (Kitazawa et al., 2003) . Likewise, treatment with endosulfan, which is in the same chemical class as dieldrin, results in increased caspase-3 expression in the heart (Ozmen, 2013) . In another proposed mechanism, dieldrin causes endoplasmic reticulum stress, which leads to decreases in endoplasmic reticulum associated protein degradation, resulting in proteotoxicity and cell death (Sun et al., 2005) . We examined whether disruption of lysosomal function and autophagy is a plausible outcome of dieldrin exposure in zebrafish hearts. Functional enrichment analysis identified alteration in gene transcripts that regulate lysosomal lumen acidification wherein examinations of individual genes responsible for lysosomal acidification are downregulated in the heart. Our search identified that three lysosomal v-ATPases have significantly reduced expression in fish fed the high dieldrin dose. Lysosomal v-ATPase uses energy from ATP hydrolysis to pump protons into the lysosomal lumen, thereby regulating the lysosomal acidity (Forgac, 2007) . Bafilomycin, a selective v-ATPase inhibitor, inhibits lysosomal acidification and protein degradation (Yoshimori et al., 1991) . Further supporting this hypothesis is our finding that mcoln1 and mcoln3 are downregulated by dieldrin treatment. Loss of function mutations in MCOLN1 result in mucolipidosis type IV, which is characterized by a build-up of lysosomes containing lipids (Chen et al., 1998) and increased lysosomal lumen pH has also been identified (Bach et al., 1999) while MCOLN3 inhibition results in defects in lysosomal acidification and impaired autophagosome maturation (Lelouvier and Puertollano, 2011) .
Furthermore, our microarray data revealed that microtubule associated proteins 1, light chain 3A and B (LC3A/B), are downregulated in the heart by dieldrin treatment, which are necessary for proper autophagosome maturation (Tanida, 2011) . These data This article has not been copyedited and formatted. The final version may differ from this version. JPET Fast Forward. Published on April 6, 2017 as DOI: 10.1124 at ASPET Journals on April 12, 2017 jpet.aspetjournals.org
suggest that lysosomal function and cellular trafficking is disrupted by dieldrin treatment.
There is only one other report on the effect of dieldrin on lysosome function, which suggest that dieldrin treatment in rat livers upregulates protease activity (Kohli et al., 1977) .
Given that microarray analysis highlighted several lysosomal proteins with reduced expression, we examined the mTOR/Akt axis which is known to inhibit lysosomal autophagy. Indeed mTOR and AKT signaling were upregulated in dieldrin treated hearts. Previous reports have also described dieldrin as an Akt activator mediated by activation of the G-Protein coupled estrogen receptor (Briz et al., 2011) .
The mTOR pathway acts as a negative regulator of lysosomal biogenesis and autophagy gene expression through inactivation of TFEB by phosphorylation, preventing its translocation into the nucleus (Roczniak-Ferguson et al., 2012) . Recent studies show that autophagy provides protection to the heart by clearing toxic protein aggregates that accumulate in the cell during cardiac stress (Martinet et al., 2009) . Our data show that dieldrin blocks this process, potentially contributing to cardiac injury.
In summary, using a zebrafish model, we characterized cardiac specific pathological signalling of dieldrin. Underlying molecular changes in dieldrin exposed hearts include inflammation and disruption of lysosomal signaling. Furthermore, dieldrin regulates genes which are related to the development of cardiac arrest and ventricular fibrillation, among many other disease associations. Future work should aim to characterize cell autonomous effect of dieldrin specifically using isolated cardiomyocytes to determine the direct action of dieldrin on the cardiac cells and its physiological impact. 
